CELLULAR BIOMEDICINE GROUP, INC. EBITDA
CELLULAR BIOMEDICINE GROUP, INC. EBITDA
- 2020-09-30: Basis Reported; EBITDA (m); Operating income -$17.69M; Depreciation and amortization (m).
- 2020-06-30: Basis Reported; EBITDA (m); Operating income -$13.37M; Depreciation and amortization (m).
- 2020-03-31: Basis Reported; EBITDA (m); Operating income -$11.43M; Depreciation and amortization (m).
- 2019-12-31: Basis Reported; EBITDA (m); Operating income -$12.80M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2020-09-30 | Reported | (m) | -$17.69M | (m) | (m) | (m) | (m) | (m) | (m) | $12.61M | (m) | $0.00 |
|---|
| 2020-06-30 | Reported | (m) | -$13.37M | (m) | (m) | (m) | (m) | (m) | (m) | $10.09M | (m) | (m) |
|---|
| 2020-03-31 | Reported | (m) | -$11.43M | (m) | (m) | (m) | $1.58M | -$9.29M | (m) | $7.76M | (m) | $1.77K |
|---|
| 2019-12-31 | Reported | (m) | -$12.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-09-30 | Reported | (m) | -$16.49M | (m) | (m) | (m) | (m) | (m) | (m) | $13.13M | (m) | $325.00 |
|---|
| 2019-06-30 | Reported | (m) | -$12.28M | (m) | (m) | (m) | (m) | (m) | (m) | $9.06M | (m) | $1.35K |
|---|
| 2019-03-31 | Reported | (m) | -$9.42M | (m) | (m) | (m) | $3.55M | -$7.94M | (m) | $5.97M | (m) | $2.40K |
|---|
| 2018-12-31 | Reported | (m) | -$9.81M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2018-09-30 | Reported | (m) | -$12.80M | (m) | (m) | (m) | (m) | (m) | (m) | $6.55M | (m) | $2.48K |
|---|
| 2018-06-30 | Reported | (m) | -$9.39M | (m) | (m) | (m) | (m) | (m) | (m) | $6.17M | (m) | $0.00 |
|---|
| 2018-03-31 | Reported | (m) | -$8.51M | (m) | (m) | (m) | $1.08M | -$5.61M | (m) | $5.27M | (m) | $2.40K |
|---|
| 2017-09-30 | Reported | (m) | -$7.13M | (m) | (m) | (m) | (m) | (m) | (m) | $4.08M | (m) | $0.00 |
|---|
| 2017-06-30 | Reported | (m) | -$6.72M | (m) | (m) | (m) | (m) | (m) | (m) | $3.35M | (m) | $0.00 |
|---|
| 2017-03-31 | Reported | (m) | -$6.29M | (m) | (m) | (m) | (m) | -$4.86M | (m) | $3.04M | (m) | $2.45K |
|---|
| 2016-09-30 | Reported | (m) | -$10.42M | (m) | (m) | (m) | (m) | (m) | (m) | $2.90M | (m) | $243.23K |
|---|
| 2016-06-30 | Reported | (m) | -$6.34M | (m) | (m) | (m) | (m) | (m) | (m) | $2.97M | (m) | $886.25K |
|---|
| 2016-03-31 | Reported | (m) | -$5.37M | (m) | (m) | (m) | (m) | -$3.58M | (m) | $2.40M | (m) | -$1.12M |
|---|
| 2015-09-30 | Reported | (m) | -$5.67M | (m) | (m) | (m) | (m) | (m) | (m) | $2.19M | (m) | -$23.40K |
|---|
| 2015-06-30 | Reported | (m) | -$4.99M | (m) | (m) | (m) | (m) | (m) | (m) | $1.32M | (m) | $52.20K |
|---|
| 2015-03-31 | Reported | (m) | -$4.30M | (m) | (m) | (m) | (m) | -$2.41M | (m) | $1.46M | (m) | $800.00 |
|---|
| 2014-09-30 | Reported | (m) | -$2.78M | (m) | (m) | (m) | (m) | (m) | (m) | $812.23K | (m) | $0.00 |
|---|
| 2014-06-30 | Reported | (m) | -$2.34M | (m) | (m) | (m) | (m) | (m) | (m) | $719.39K | (m) | $0.00 |
|---|
| 2014-03-31 | Reported | (m) | -$1.88M | (m) | (m) | (m) | (m) | -$2.38M | (m) | $498.15K | (m) | (m) |
|---|
| 2013-09-30 | Reported | (m) | -$1.67M | (m) | (m) | (m) | (m) | (m) | (m) | $196.52K | (m) | $386.49K |
|---|
| 2013-06-30 | Reported | (m) | -$2.26M | (m) | (m) | (m) | (m) | (m) | (m) | $639.28K | (m) | (m) |
|---|
| 2013-03-31 | Reported | (m) | -$5.09M | (m) | (m) | (m) | (m) | -$1.82M | (m) | $480.50K | (m) | (m) |
|---|
| 2012-09-30 | Reported | (m) | -$1.42M | (m) | (m) | (m) | (m) | (m) | (m) | $687.75K | (m) | (m) |
|---|
| 2012-06-30 | Reported | (m) | -$1.15M | (m) | (m) | (m) | (m) | (m) | (m) | $55.18K | (m) | $109.00 |
|---|
| 2012-03-31 | Reported | (m) | -$1.22M | (m) | (m) | (m) | (m) | -$1.91M | (m) | $255.95K | (m) | (m) |
|---|
| 2011-09-30 | Reported | (m) | -$358.71K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
|---|
| 2011-06-30 | Reported | (m) | -$339.13K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
|---|
| 2011-03-31 | Reported | (m) | -$324.19K | (m) | (m) | (m) | (m) | -$112.70K | (m) | (m) | (m) | (m) |
|---|
| 2010-09-30 | Reported | (m) | -$187.61K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
|---|
| 2010-06-30 | Reported | (m) | -$367.44K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2020-09-30 | Rolling | (m) | -$55.28M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-06-30 | Rolling | (m) | -$54.09M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-03-31 | Rolling | (m) | -$53.01M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-12-31 | Reported | (m) | -$50.99M | (m) | (m) | (m) | (m) | -$39.65M | (m) | $37.67M | (m) | $1.04K |
|---|
| 2019-12-31 | Rolling | (m) | -$50.99M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-09-30 | Rolling | (m) | -$48.00M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-06-30 | Rolling | (m) | -$44.31M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-03-31 | Rolling | (m) | -$41.41M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2018-12-31 | Reported | (m) | -$40.51M | (m) | (m) | (m) | (m) | -$25.11M | (m) | $24.15M | (m) | $4.95K |
|---|
| 2018-12-31 | Rolling | (m) | -$40.51M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2017-12-31 | Reported | (m) | -$27.58M | (m) | (m) | (m) | (m) | -$18.59M | (m) | $14.61M | (m) | $2.45K |
|---|
| 2016-12-31 | Reported | (m) | -$28.42M | (m) | (m) | (m) | (m) | -$15.87M | (m) | $11.48M | (m) | $4.09K |
|---|
| 2015-12-31 | Reported | (m) | -$20.85M | (m) | (m) | (m) | (m) | -$11.75M | (m) | $7.57M | (m) | -$728.60K |
|---|
| 2014-12-31 | Reported | (m) | -$12.44M | (m) | (m) | (m) | (m) | -$9.72M | (m) | $3.15M | (m) | $0.00 |
|---|
| 2013-12-31 | Reported | (m) | -$11.35M | (m) | (m) | (m) | (m) | -$8.46M | (m) | $2.04M | (m) | $344.45K |
|---|
| 2012-12-31 | Reported | (m) | -$7.06M | (m) | (m) | (m) | (m) | -$7.46M | (m) | $3.21M | (m) | $0.00 |
|---|
| 2011-12-31 | Reported | (m) | -$1.04M | (m) | (m) | (m) | (m) | $347.87K | (m) | (m) | (m) | $0.00 |
|---|
| 2010-12-31 | Reported | (m) | $311.11K | (m) | (m) | (m) | (m) | -$90.21K | (m) | (m) | (m) | $0.00 |
|---|